KK
MRNA icon

KLP Kapitalforvaltning’s Moderna MRNA Stock Holding History

KLP Kapitalforvaltning’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.46M Sell
77,900
-1,600
-2% -$82.8K 0.02% 490
2026
Q1 		$4.04M Buy
79,500
+1,100
+1% +$51.3K 0.02% 529
2025
Q4 		$2.31M Buy
78,400
+6,000
+8% +$163K 0.01% 667
2025
Q3 		$1.87M Hold
72,400
– – 0.01% 730
2025
Q2 		$2M Sell
72,400
-34,400
-32% -$906K 0.01% 669
2025
Q1 		$3.03M Hold
106,800
– – 0.01% 555
2024
Q4 		$4.44M Buy
+106,800
New +$5.1M 0.02% 507

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

KLP Kapitalforvaltning's MRNA Position: Q2 2026 in Review

KLP Kapitalforvaltning reduced its Moderna (MRNA) stake by 2% in Q2 2026, selling an estimated $82.8K and leaving 77,900 shares worth $5.46M. The position accounts for 0.02% of the portfolio, ranked #490.

KLP Kapitalforvaltning first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • KLP Kapitalforvaltning held 77,900 shares of Moderna worth $5.46M as of Q2 2026.
  • KLP Kapitalforvaltning sold 1,600 Moderna shares in Q2 2026, an estimated $82.8K.
  • Moderna made up 0.02% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #490 holding.
  • KLP Kapitalforvaltning first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.